Buy Indoco Remedies; target of Rs 583: Angel Broking

Angel Broking is bullish on Indoco Remedies and has recommended buy rating on the stock with a target of Rs 583 in its October 28, 2011 research report.
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney IThe Winning Leap SME Special
Moneycontrol

Home » News » Recommendations

Oct 31, 2011, 03.44 PM | Source: Moneycontrol.com

Buy Indoco Remedies; target of Rs 583: Angel Broking

Angel Broking is bullish on Indoco Remedies and has recommended buy rating on the stock with a target of Rs 583 in its October 28, 2011 research report.

Like this story, share it with millions of investors on M3

Buy Indoco Remedies; target of Rs 583: Angel Broking

Angel Broking is bullish on Indoco Remedies and has recommended buy rating on the stock with a target of Rs 583 in its October 28, 2011 research report.

Post Your Comments

Share Cancel

(more)

, Angel Broking |

Angel Broking is bullish on Indoco Remedies and has recommended buy rating on the stock with a target of Rs 583 in its October 28, 2011 research report.

“For 2QFY2012, Indoco Remedies (Indoco) declared in-line results at the revenue front, reporting growth of 9.4% yoy. However, on the net profit front, growth came in lower than expected, declining by 9.4% yoy. This was mainly on account of OPM declining by 95bp yoy to 12.4% (13.4%), lower than our estimates. The domestic formulation segment grew moderately by 5.3% yoy during the quarter, contributing 64.4% to the total revenue, whereas formulations exports increased by 23.6% yoy.”

“Indoco reported net sales of Rs 145cr (Rs 132cr), up 9.4% yoy, almost in-line with our expectation of Rs 148cr for 2QFY2012, mainly on account of lower sales from the domestic high-margin formulations segment. Gross margin came in at 54.2%, in-line with 2QFY2011. OPM decreased by 95bp yoy to 12.4% (13.4%). Net profit for the quarter came in at Rs 13.8cr, 23.7% below our estimate of Rs 18.1cr.”

“We expect net sales to post a 19.6% CAGR to Rs 685cr and EPS to post a 15.6% CAGR to Rs 55.5 over FY2011-13E. At Rs 373, the stock is trading at 8.8x and 6.7x FY2012E and FY2013E earnings, respectively. We recommend Buy on the stock with a revised target price of Rs 583,” says Angel Broking research report.  

Institutional holding more than 40% in Indian cos

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click here

Buy, Hold, Sell ? Hear it first on M3
Buy Indoco Remedies; target of Rs 583: Angel Broking

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login